In this study, for the first time, the association between IDO expression in the tumor microenvironment and systemic concentrations of IDO metabolites in cervical cancer patients was comprehensively investigated, using a validated IDO-specific antibody (51). Here, IDO1 is linked to cervical carcinoma.